Menu
Back to Journals » Vascular Health and Risk Management » Volume 12
Review
SGLT2 inhibitors or GLP-1 receptor agonists as second-line therapy in type 2 diabetes: patient selection and perspectives
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 34,850 | Dovepress* | 13,957+ | 2,989 | 16,946 | |
| PubMed Central* | 20,893 | 2,460 | 23,353 | ||
| Totals | 34,850 | 5,449 | 40,299 | ||
|
*Since 4 June 2016 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 6 | 2 | 0 | 0 | 1 | 3 |
View citations on PubMed Central and Google Scholar